Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosomal binding domain 2 pseudogene 38 (HMGN2P38)
- Target
- HMGN2P38
- Molecular classification
- Pseudogene, Non-coding DNA, High mobility group nucleosomal binding domain family (by sequence homology)
01
Overview
High mobility group nucleosomal binding domain 2 pseudogene 38 (HMGN2P38) is a genomic DNA sequence highly homologous to the functional HMGN2 gene, but is classified as a pseudogene, meaning it is not believed to produce a functional protein product. Pseudogenes are generally considered noncoding remnants of genes, although some have been found to be transcribed and, in certain cases, have regulatory functions such as acting as sources of RNA molecules that regulate related genes through complex RNA-based mechanisms. There is currently no evidence that HMGN2P38 encodes a protein, acts as a receptor, or is involved in drug interactions or disease processes.
02
Mechanism of action
Not applicable
03
Biological functions
No direct protein-coding functionPotential for regulatory roles as described for some pseudogenes (e.g., acting as competing endogenous RNA, source of noncoding RNAs, or influencing homologous gene expression), but there is no direct evidence for such activity for HMGN2P38 specifically
04
Disease associations
No established role in diseasePseudogenes in general can sometimes play regulatory, decoy, or other roles in cancer or development, but there is no evidence of such for HMGN2P38 specifically
Beyond the preview
Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 38 (HMGN2P38).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 38 (HMGN2P38).